Analyst Viewpoint
Increase in number of accidents and trauma cases and rise in stem cell biology research are fueling the amniotic membrane market size. Amniotic membrane is used in various treatments in wound healing and surgeries as it helps reduce inflammation and scarring. Technological advancements in regenerative medicine and rise in membrane transplantation are some of the major market drivers.
Leading players in the market invest in new product launches, thereby driving market expansion. Companies invest in technological advancements in the healthcare sector to meet customer demands and provide innovative products. Moreover, they focus on conducting clinical trials to receive authorized product approval to enhance their brand reach in global markets.
Amniotic membrane is extensively used for treating various ocular surface disorders and injuries due to its unique properties. Amniotic Membrane Transplantation (AMT) helps repair and reconstruct the ocular surface in cases of corneal damage, such as persistent corneal epithelial defects, corneal ulcers, and chemical burns.
The membrane acts as a scaffold for epithelial cell migration and promotes healing, reducing inflammation, and scarring.
Amniotic membrane graft refers to a surgical procedure in which a thin, transparent membrane derived from the innermost layer of the placenta (amniotic membrane) is used as a graft or patch to treat various medical conditions. Amniotic membrane grafts for ophthalmic surgery ensure the management of ocular surface disorders, corneal defects, conjunctival reconstruction, and other eye-related conditions.
Cryopreservation techniques, bioengineering and tissue engineering, biocompatible scaffolds, amniotic fluid-derived products, and topical formulations are some of the major advancements in amniotic membrane technology. These advancements offer enhanced tissue repair, regeneration, and therapeutic modulation.
Sudden, forceful events cause traumatic injuries including fractures, concussions, cuts, and burns, requiring prompt medical attention for diagnosis, treatment, and recovery. Road accidents are the leading cause of traumatic injuries among young adults and children.
Violation of road safety regulations and rise in traffic congestion are fueling accident rates across the globe. Thus, surge in number of accidents and trauma cases is bolstering the amniotic membrane market revenue. According to the World Health Organization (WHO) report published in June 2022, approximately 1.3 million fatalities are registered every year as a result of road traffic accidents.
Amniotic membrane is utilized in regenerative medicine products as it helps in tissue repair, wound healing, and modulation of inflammatory responses, offering potential treatments for various medical conditions. Increase in severe injuries among laborers during fieldwork is driving the demand for effective and quick healing treatments.
According to the United States Department of Labor, over 5,190 fatal work injuries were reported in the United States in 2021, which increased from 4,764 cases compared to 2020. Hence, rise in demand for regenerative medicine products is augmenting market statistics.
Amniotic membrane is a crucial element in stem cell biology research due to its unique properties. It serves as a substrate for stem cell culture, providing a supportive environment for cell proliferation, differentiation, and tissue regeneration studies. Stem cell biology research is conducted to enhance regenerative medicine, disease modeling, and drug discovery.
Increase in investments in research and development activities are supporting the healthcare industry. Thus, surge in stem cell biology research is augmenting the amniotic membrane market development.
As per the amniotic membrane market forecast, technological advancements in surgical sector and increase in incorporation of amniotic membrane in regenerative medicine are likely to drive market value. Amniotic tissue graft helps in wound healing during complex surgeries, thereby being extensively utilized by surgeons.
For instance, in October 2022, Membrane Wrap - Hydro, the hydrated human amnion membrane allograft product by BioLab Sciences, was recognized by the United States Food and Drug Administration (FDA) Tissue Reference Group (TRG) as a human cell, tissue/ cellular/tissue-based product. The product is indicated for the management of surgical wounds and other wounds.
According to the market analysis, North America dominated the global market in 2022. Well-established healthcare infrastructure and rise in investments in drug development technologies are likely to propel amniotic membrane market share during the forecast period. Surge in reimbursement of medical products makes medical facilities more affordable in this region. Moreover, availability and easy access to medical services is boosting market progress.
For instance, according to the data published by the United States Centers for Medicare & Medicaid Services in February 2023, the national healthcare expenditure has increased by 2.7% to US$ 4.3 trillion in 2021 compared to 2020.
As per the latest amniotic membrane market trends, technological advancements in regenerative medicines offer lucrative opportunities to the companies operating in this industry. Leading players in the market are launching new products to enhance their product portfolio.
Increase in investments in research and development allow companies to develop innovative products to meet customer demands. Conducting multiple clinical trials help companies to seek product approvals.
Some of the players in the amniotic membrane market are Integra LifeSciences, MiMedx Group, Inc., Skye Biologics Holdings, LLC, Corza Ophthalmology, Amnio Technology, LLC, Applied Biologics, BioTissue, Stryker, Osiris Therapeutics, Inc., and Human Regenerative Technologies, LLC.
These companies have been profiled in the amniotic membrane market report based on various parameters including company overview, business segments, product portfolio, recent developments, business strategies, and financial overview.
| Attribute | Detail |
|---|---|
| Market Size in 2022 | US$ 2.3 Bn |
| Market Forecast (Value) in 2031 | US$ 5.2 Bn |
| Growth Rate (CAGR) | 9.9% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Tons | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 2.3 Bn in 2022
It is projected to register a CAGR of 9.9% from 2023 to 2031
Increase in number of accidents and trauma cases and rise in stem cell biology research
North America was the most lucrative region in 2022
Integra LifeSciences, MiMedx Group, Inc., Skye Biologics Holdings, LLC, Corza Ophthalmology, Amnio Technology, LLC, Applied Biologics, BioTissue, Stryker, Osiris Therapeutics, Inc., and Human Regenerative Technologies, LLC
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Amniotic Membrane Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Amniotic Membrane Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Amniotic Membrane Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Cryopreserved Amniotic Membrane
6.3.2. Lylophilization Amniotic Membrane
6.4. Market Attractiveness Analysis, by Product
7. Global Amniotic Membrane Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Surgical Wounds
7.3.2. Ophthalmology
7.3.3. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Amniotic Membrane Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Specialized Clinics
8.3.4. Research Centers & Laboratories
8.4. Market Attractiveness Analysis, by End-user
9. Global Amniotic Membrane Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Amniotic Membrane Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product, 2017–2031
10.3.1. Cryopreserved Amniotic Membrane
10.3.2. Lylophilization Amniotic Membrane
10.4. Market Value Forecast, by Application, 2017–2031
10.4.1. Surgical Wounds
10.4.2. Ophthalmology
10.4.3. Others
10.5. Market Value Forecast, by End-user, 2017–2031
10.5.1. Hospitals
10.5.2. Ambulatory Surgical Centers
10.5.3. Specialized Clinics
10.5.4. Research Centers & Laboratories
10.6. Market Value Forecast, by Country, 2017–2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Product
10.7.2. By Application
10.7.3. By End-user
10.7.4. By Country
11. Europe Amniotic Membrane Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product, 2017–2031
11.3.1. Cryopreserved Amniotic Membrane
11.3.2. Lylophilization Amniotic Membrane
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Surgical Wounds
11.4.2. Ophthalmology
11.4.3. Others
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals
11.5.2. Ambulatory Surgical Centers
11.5.3. Specialized Clinics
11.5.4. Research Centers & Laboratories
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Application
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Amniotic Membrane Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product, 2017–2031
12.3.1. Cryopreserved Amniotic Membrane
12.3.2. Lylophilization Amniotic Membrane
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Surgical Wounds
12.4.2. Ophthalmology
12.4.3. Others
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals
12.5.2. Ambulatory Surgical Centers
12.5.3. Specialized Clinics
12.5.4. Research Centers & Laboratories
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Application
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Amniotic Membrane Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product, 2017–2031
13.3.1. Cryopreserved Amniotic Membrane
13.3.2. Lylophilization Amniotic Membrane
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Surgical Wounds
13.4.2. Ophthalmology
13.4.3. Others
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals
13.5.2. Ambulatory Surgical Centers
13.5.3. Specialized Clinics
13.5.4. Research Centers & Laboratories
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Application
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Amniotic Membrane Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Product, 2017–2031
14.3.1. Cryopreserved Amniotic Membrane
14.3.2. Lylophilization Amniotic Membrane
14.4. Market Value Forecast, by Application, 2017–2031
14.4.1. Surgical Wounds
14.4.2. Ophthalmology
14.4.3. Others
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals
14.5.2. Ambulatory Surgical Centers
14.5.3. Specialized Clinics
14.5.4. Research Centers & Laboratories
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Application
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Integra LifeSciences
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. MiMedx Group, Inc.
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Skye Biologics Holdings, LLC
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Corza Ophthalmology
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Amnio Technology, LLC
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Applied Biologics
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. BioTissue
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Stryker
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Osiris Therapeutics, Inc.
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Human Regenerative Technologies, LLC
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
List of Tables
Table 01: Global Amniotic Membrane Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 02: Global Amniotic Membrane Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 03: Global Amniotic Membrane Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Amniotic Membrane Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Amniotic Membrane Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Amniotic Membrane Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 07: North America Amniotic Membrane Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 08: North America Amniotic Membrane Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Amniotic Membrane Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Amniotic Membrane Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 11: Europe Amniotic Membrane Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 12: Europe Amniotic Membrane Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Amniotic Membrane Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Amniotic Membrane Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 15: Asia Pacific Amniotic Membrane Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 16: Asia Pacific Amniotic Membrane Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America Amniotic Membrane Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Amniotic Membrane Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 19: Latin America Amniotic Membrane Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 20: Latin America Amniotic Membrane Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Amniotic Membrane Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Amniotic Membrane Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 23: Middle East & Africa Amniotic Membrane Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 24: Middle East & Africa Amniotic Membrane Market Size (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Amniotic Membrane Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031
Figure 02: Global Amniotic Membrane Market Revenue (US$ Mn), by Product, 2022
Figure 03: Global Amniotic Membrane Market Value Share, by Product, 2022
Figure 04: Global Amniotic Membrane Market Revenue (US$ Mn), by Application, 2022
Figure 05: Global Amniotic Membrane Market Value Share, by Application, 2022
Figure 06: Global Amniotic Membrane Market Revenue (US$ Mn), by End-user, 2022
Figure 07: Global Amniotic Membrane Market Value Share, by End-user, 2022
Figure 08: Global Amniotic Membrane Market Value Share, by Region, 2022
Figure 09: Global Amniotic Membrane Market Value (US$ Mn) Forecast, 2017–2031
Figure 10: Global Amniotic Membrane Market Value Share Analysis, by Product, 2022–2031
Figure 11: Global Amniotic Membrane Market Attractiveness Analysis, by Product, 2023–2031
Figure 12: Global Amniotic Membrane Market Value Share Analysis, by Application, 2022–2031
Figure 13: Global Amniotic Membrane Market Attractiveness Analysis, by Application, 2023–2031
Figure 14: Global Amniotic Membrane Market Value Share Analysis, by End-user, 2022–2031
Figure 15: Global Amniotic Membrane Market Attractiveness Analysis, by End-user, 2022-2031
Figure 16: Global Amniotic Membrane Market Value Share Analysis, by Region, 2022–2031
Figure 17: Global Amniotic Membrane Market Attractiveness Analysis, by Region, 2022-2031
Figure 18: North America Amniotic Membrane Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 19: North America Amniotic Membrane Market Attractiveness Analysis, by Country, 2023–2031
Figure 20: North America Amniotic Membrane Market Value Share Analysis, by Country, 2022–2031
Figure 21: North America Amniotic Membrane Market Value Share Analysis, by Product, 2022–2031
Figure 22: North America Amniotic Membrane Market Value Share Analysis, by Application, 2022–2031
Figure 23: North America Amniotic Membrane Market Value Share Analysis, by End-user, 2022–2031
Figure 24: North America Amniotic Membrane Market Attractiveness Analysis, by Product, 2023–2031
Figure 25: North America Amniotic Membrane Market Attractiveness Analysis, by Application, 2023–2031
Figure 26: North America Amniotic Membrane Market Attractiveness Analysis, by End-user, 2023–2031
Figure 27: Europe Amniotic Membrane Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 28: Europe Amniotic Membrane Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 29: Europe Amniotic Membrane Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 30: Europe Amniotic Membrane Market Value Share Analysis, by Product, 2022–2031
Figure 31: Europe Amniotic Membrane Market Value Share Analysis, by Application, 2022–2031
Figure 32: Europe Amniotic Membrane Market Value Share Analysis, by End-user, 2022–2031
Figure 33: Europe Amniotic Membrane Market Attractiveness Analysis, by Product, 2023–2031
Figure 34: Europe Amniotic Membrane Market Attractiveness Analysis, by Application, 2023–2031
Figure 35: Europe Amniotic Membrane Market Attractiveness Analysis, by End-user, 2023–2031
Figure 36: Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 37: Asia Pacific Amniotic Membrane Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 38: Asia Pacific Amniotic Membrane Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 39: Asia Pacific Amniotic Membrane Market Value Share Analysis, by Product, 2022–2031
Figure 40: Asia Pacific Amniotic Membrane Market Value Share Analysis, by Application, 2022–2031
Figure 41: Asia Pacific Amniotic Membrane Market Value Share Analysis, by End-user, 2022–2031
Figure 42: Asia Pacific Amniotic Membrane Market Attractiveness Analysis, by Product, 2023–2031
Figure 43: Asia Pacific Amniotic Membrane Market Attractiveness Analysis, by Application, 2023–2031
Figure 44: Asia Pacific Amniotic Membrane Market Attractiveness Analysis, by End-user, 2023–2031
Figure 45: Latin America Amniotic Membrane Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 46: Latin America Amniotic Membrane Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 47: Latin America Amniotic Membrane Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 48: Latin America Amniotic Membrane Market Value Share Analysis, by Product, 2022–2031
Figure 49: Latin America Amniotic Membrane Market Value Share Analysis, by Application, 2022–2031
Figure 50: Latin America Amniotic Membrane Market Value Share Analysis, by End-user, 2022–2031
Figure 51: Latin America Amniotic Membrane Market Attractiveness Analysis, by Product, 2023–2031
Figure 52: Latin America Amniotic Membrane Market Attractiveness Analysis, by Application, 2023–2031
Figure 53: Latin America Amniotic Membrane Market Attractiveness Analysis, by End-user, 2023–2031
Figure 54: Middle East & Africa Amniotic Membrane Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 55: Middle East & Africa Amniotic Membrane Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 56: Middle East & Africa Amniotic Membrane Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 57: Middle East & Africa Amniotic Membrane Market Value Share Analysis, by Product, 2022–2031
Figure 58: Middle East & Africa Amniotic Membrane Market Value Share Analysis, by Application, 2022–2031
Figure 59: Middle East & Africa Amniotic Membrane Market Value Share Analysis, by End-user, 2022–2031
Figure 60: Middle East & Africa Amniotic Membrane Market Attractiveness Analysis, by Product, 2023–2031
Figure 61: Middle East & Africa Amniotic Membrane Market Attractiveness Analysis, by Application, 2023–2031
Figure 62: Middle East & Africa Amniotic Membrane Market Attractiveness Analysis, by End-user, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Amniotic Membrane Market
